about
Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline include...
Read More
3.66
0.00
(0.00%)
607.9K
XNAS Volume
XNAS 10 Aug, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Opus Genetics Inc is on 13 Aug 2026 for the purpose of Opus Genetics Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Neutral
Opus Genetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..